Figure 2.

A: A 12-lead electrocardiograms in Case 2. B: Cardiac magnetic resonance imaging at diastole (a) and systole (b), dark-blood sequence for non-enhanced T2-weighted imaging (c) and delayed gadolinium-enhanced imaging (d) performed at day 28. C: Changes in the parameters of the left ventricular structure and function as assessed by a transthoracic echocardiogram. D: Clinical course. E: Cytokine expressions. F: CK, and CRP levels. LVPWTd: left ventricular posterior wall thickness at end-diastole, LVIDd: left ventricular diastolic internal dimension, LVIDs: left ventricular systolic internal dimension, LVEF: left ventricular ejection fraction